SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-22-033953
Filing Date
2022-06-21
Accepted
2022-06-21 15:52:51
Documents
23

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea161783-s1_inmedpharma.htm   iXBRL S-1 407268
2 OPINION OF NORTON ROSE FULBRIGHT CANADA LLP ea161783ex5-1_inmedpharma.htm EX-5.1 14535
3 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea161783ex23-1_inmedpharma.htm EX-23.1 1841
4 FILING FEE TABLE ea161783ex-fee_inmedpharma.htm EX-FILING FEES 31506
9 GRAPHIC image_001.jpg GRAPHIC 5649
10 GRAPHIC image_002.jpg GRAPHIC 16390
11 GRAPHIC image_003.jpg GRAPHIC 44478
12 GRAPHIC image_004.jpg GRAPHIC 26997
13 GRAPHIC image_005.jpg GRAPHIC 6322
14 GRAPHIC ex5-1_001.jpg GRAPHIC 3482
15 GRAPHIC ex5-1_002.jpg GRAPHIC 3204
  Complete submission text file 0001213900-22-033953.txt   896656

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE inm-20220331.xsd EX-101.SCH 3280
6 XBRL DEFINITION FILE inm-20220331_def.xml EX-101.DEF 5828
7 XBRL LABEL FILE inm-20220331_lab.xml EX-101.LAB 10174
8 XBRL PRESENTATION FILE inm-20220331_pre.xml EX-101.PRE 5656
17 EXTRACTED XBRL INSTANCE DOCUMENT ea161783-s1_inmedpharma_htm.xml XML 1348
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-265731 | Film No.: 221028012
SIC: 2834 Pharmaceutical Preparations